HEIDI VAWDREY: Open Payments
NPI 1184144594 · RIVERTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$333 in 14 payments from 11 companies in 2025. Trend: 2023 $747 · 2024 $697 · 2025 $333
Food & beverage: $333
| Company | Payments | Amount |
|---|---|---|
| Exeltis, USA Inc. | 1 | $67 |
| ABBVIE INC. | 3 | $65 |
| Amgen Inc. | 2 | $55 |
| Lundbeck LLC | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Novo Nordisk Inc | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $16 |
| Inspire Medical Systems, Inc. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: TWIRLA, EVENITY, VRAYLAR, REXULTI, CAPLYTA, Ozempic, SYNTHROID, Sunosi.
Industry payments across UT — which companies pay providers there.
